VHCP Management II

Latest statistics and disclosures from VHCP Management II's latest quarterly 13F-HR filing:

VHCP Management II portfolio companies for December 2016 quarter

Company (Ticker) Portfolio Weight Share Count Price Last Trade
Avexis 23.71 1.04M 47.73 0.00
BioCryst Pharmaceuticals (BCRX) 18.43 6.07M +6.00% 6.33 8.79
Edge Therapeutics 11.59 1.93M 12.50 0.00
Dbv Technologies 8.97 373617 50.04 0.00
Ascendis Pharma A S 7.00 721152 20.24 0.00
Audentes Therapeutics Inc Com stock 3.96 458882 17.97 0.00
Ra Pharmaceuticals 3.95 542500 NEW 15.19 0.00
Cytomx Therapeutics 3.05 577831 10.99 0.00
Colucid Pharmaceuticals 2.78 159110 36.40 0.00
Axovant Sciences 2.56 429590 12.42 0.00
Heron Therapeutics 2.55 405901 13.10 0.00
Coherus Biosciences 1.75 129629 28.15 0.00
D Stemline Therapeutics 1.62 315980 10.70 0.00
Alcobra 1.55 1.54M 2.10 0.00
ARCA biopharma (ABIO) 1.47 1.08M 2.85 2.65
Akari Therapeutics 1.25 369490 7.04 0.00
Ocera Therapeutics 1.23 1.22M +11.00% 2.10 0.00
Lipocine 0.74 420000 3.68 0.00
Aeglea Biotherapeutics 0.73 350133 4.35 0.00
Kalvista Pharmaceuticals 0.63 221651 NEW 5.96 0.00
Adverum Biotechnologies 0.39 280000 2.90 0.00
Pronai Therapeutics 0.09 130798 1.49 0.00

Past 13F-HR SEC Filings for VHCP Management II